These results suggest that abnormally activated mTOR activity could may be responsible for impaired autophagy, regulate the survival of autoreactive T cell during HT, and could thus lead to design new therapeutic options for treatment Hashimoto’s thyroiditis. The gene discussed is MTOR; the disease is hematocrit.